These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7865354)

  • 1. The role of cytokines in toxoplasmosis.
    Hunter CA; Subauste CS; Remington JS
    Biotherapy; 1994; 7(3-4):237-47. PubMed ID: 7865354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to Toxoplasma gondii.
    Subauste CS; Remington JS
    Curr Opin Immunol; 1993 Aug; 5(4):532-7. PubMed ID: 8216929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxoplasmic encephalitis in AIDS patients and experimental models for study of the disease and its treatment.
    Suzuki Y; Remington JS
    Res Immunol; 1993 Jan; 144(1):66-7. PubMed ID: 8451522
    [No Abstract]   [Full Text] [Related]  

  • 5. Genes, cells and cytokines in resistance against development of toxoplasmic encephalitis.
    Suzuki Y
    Immunobiology; 1999 Dec; 201(2):255-71. PubMed ID: 10631575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines involved in Toxoplasmic encephalitis.
    Sarciron ME; Gherardi A
    Scand J Immunol; 2000 Dec; 52(6):534-43. PubMed ID: 11119257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS).
    Potasman I; Resnick L; Luft BJ; Remington JS
    Ann Intern Med; 1988 Jan; 108(1):49-51. PubMed ID: 3337515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS.
    Eggers C; Gross U; Klinker H; Schalke B; Stellbrink HJ; Kunze K
    J Neurol; 1995 Oct; 242(10):644-9. PubMed ID: 8568525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of cytokine profile during the treatment of cerebral toxoplasmosis in HIV-infected patients.
    Meira Cda S; Pereira-Chioccola VL; Vidal JE; Motoie G; Costa-Silva TA; Gava R;
    J Immunol Methods; 2015 Nov; 426():14-8. PubMed ID: 26177476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of Toxoplasma gondii.
    Wong SY; Remington JS
    AIDS; 1993 Mar; 7(3):299-316. PubMed ID: 8471191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of major histocompatibility complex class II antigens and levels of interferon-gamma, tumour necrosis factor, and interleukin-6 in cerebrospinal fluid and serum in Toxoplasma gondii-infected SCID and immunocompetent C.B-17 mice.
    Schlüter D; Deckert-Schlüter M; Schwendemann G; Brunner H; Hof H
    Immunology; 1993 Mar; 78(3):430-5. PubMed ID: 8478025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both lymphotoxin-alpha and TNF are crucial for control of Toxoplasma gondii in the central nervous system.
    Schlüter D; Kwok LY; Lütjen S; Soltek S; Hoffmann S; Körner H; Deckert M
    J Immunol; 2003 Jun; 170(12):6172-82. PubMed ID: 12794148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does human toxoplasmosis involve an imbalance in T1/T2 cytokines?
    Gómez Marín JE; Pinon JM; Bonhomme A; Guenounou M
    Med Hypotheses; 1997 Feb; 48(2):161-9. PubMed ID: 9076698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii: an AIDS enhancing cofactor.
    Lin DS; Bowman DD
    Med Hypotheses; 1992 Oct; 39(2):140-2. PubMed ID: 1334211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of tissue cyst-specific antigens in reactivating toxoplasmosis.
    McHugh TD; Bathgate T; Mangan J; Johnson JD; Holliman RE; Butcher PD
    J Med Microbiol; 1997 Jul; 46(7):587-95. PubMed ID: 9236743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation.
    Deckert-Schlüter M; Rang A; Weiner D; Huang S; Wiestler OD; Hof H; Schlüter D
    Lab Invest; 1996 Dec; 75(6):827-41. PubMed ID: 8973478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-β in Toxoplasmosis: Friend or foe?
    Zare-Bidaki M; Assar S; Hakimi H; Abdollahi SH; Nosratabadi R; Kennedy D; Arababadi MK
    Cytokine; 2016 Oct; 86():29-35. PubMed ID: 27449809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spinal cord toxoplasmosis in human immunodeficiency virus infection/acquired immunodeficiency syndrome.
    García-García C; Castillo-Álvarez F; Azcona-Gutiérrez JM; Herraiz MJ; Ibarra V; Oteo JA
    Infect Dis (Lond); 2015 May; 47(5):277-82. PubMed ID: 25835092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
    Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
    Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogeny and immunological control of toxoplasmosis.
    Derouin F
    Braz J Med Biol Res; 1992; 25(12):1163-9. PubMed ID: 1341911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.